NCT05615142 2024-04-17Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.Sichuan UniversityPhase 1 Recruiting9 enrolled
NCT05605613 2022-11-09PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled TrialThe First Affiliated Hospital of Zhengzhou UniversityPhase 2/3 Unknown150 enrolled